ABUS — ARBUTUS BIOPHARMA CORP

Ownership history in TWO SIGMA SECURITIES, LLC  ·  6 quarters on record

This page tracks every 13F SEC filing in which TWO SIGMA SECURITIES, LLC reported a position in ARBUTUS BIOPHARMA CORP (ABUS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2024 Q4)
Avg. % of fund
0.01%
First filed
2017 Q3
Last filed
2025 Q3
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 11,534 -5,251 -31.3% 0.01% $52K $4.54
2025 Q2 REDUCED 16,785 -2,690 -13.8% 0.01% $52K $3.09
2024 Q4 REDUCED 19,475 -1,760 -8.3% 0.01% $64K $3.27
2023 Q1 ADDED 21,235 +9,941 +88.0% 0.00% $64K $3.03
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ABUS price (monthly, adj. close)

Other funds also holding ABUS

As of 2025 Q4 — sorted by position size

Whitefort Capital Management, LP 3Y 16.41% Rangeley Capital, LLC 3.36% ADAR1 Capital Management, LLC 1.89% Two Seas Capital LP 3Y 1.25% Western Standard LLC 3Y 7Y 1.13% STEMPOINT CAPITAL LP 0.81% BlackBarn Capital Partners LP 0.59% SHERBROOKE PARK ADVISERS LLC 3Y 0.35% AlphaCentric Advisors LLC 3Y 0.23% Murchinson Ltd. 3Y 0.21%
← Back to TWO SIGMA SECURITIES, LLC Holdings